Cardiac Devices research Amsterdam
@CardiacDevices_
Followers
77
Following
20
Media
11
Statuses
31
Leading research group on S-ICD, leadless pacemaker and wearable technology. Initiator of PRAETORIAN trials. Opinions are our own.
Joined June 2021
Great LBCT presented by @KnopsReinoud! First results of the randomized PRAETORIAN DFT trial. Validation of the PRAETORIAN score #HRS2023 #EPeeps #NOLA
0
5
8
Recap of yesterday; first day of #HRS2023 🙌🏻. We kicked off with great presentations on Quality of Life between S-ICD and TV-IVD patients and defibrillation treshold after S-ICD replacements. Enjoying catching up with friends! Lots more to come! @KnopsReinoud
0
1
7
RT @EJSMD: .@CardiacDevices_ —. S-ICD DFTs tested at elective generator replacement. ✳️45 pts.✳️6yr mean post implant.✳️Shock impedance….
0
6
0
RT @fleurtjong: 🚨 New #Europace paper out! We report a long-term mortality benefit of RM vs. non-RM follow-up in a propensity matched all-c….
pubmed.ncbi.nlm.nih.gov
Remote monitoring was associated with a reduction in long-term all-cause and cardiac mortality compared with traditional office visits in a real-world ICD population.
0
5
0
Worsening tricuspid regurgitation 💨 after ICD implantation: due to the lead or natural progression?. Glad to share our latest article in @IJCardio, comparing S-ICD vs. transvenous ICD patients! .@fleurtjong @KnopsReinoud .
internationaljournalofcardiology.com
Transvenous implantable cardioverter-defibrillators (TV-ICDs) are associated with greater tricuspid regurgitation (TR) severity, which leads to increased mortality. The pathophysiology is assumed to...
0
0
2
RT @ehj_ed: EHJ issue 43 - 47 out now!. Our EHJ Focus Issue on arrhythmias wraps up novel risk factors for atrial fibrillation, conduction….
0
2
0
RT @KnopsReinoud: New publication in EHJ!!Important data for shared decisions making in (S-)ICD therapy. https://t.….
0
9
0
RT @fleurtjong: Congratulations to our AI MSc student #FloorvanLieshout, who won the prestigious Bill and Gary Sanders Poster Award at #Cin….
0
3
0
RT @fleurtjong: Proud to see our Research Fellow #MaartenKolk on this stage together with great researchers! The Future Is Now! #MachineLea….
0
1
0
Great talk of Maarten Kolk on the last but not least day of ESC 2022 #ESC #amsterdamumc #remotemonitoring #ICD
0
1
6
Our manuscript on device-related complications in the PRAETORIAN trial is now available at European Heart Journal 🙌🏻:. @KnopsReinoud @ESC_Journals #EHJ #Cardiotwitter #EPeeps.
academic.oup.com
AbstractBackground. The subcutaneous implantable cardioverter-defibrillator (S-ICD) is developed to overcome lead-related complications and systemic infect
0
3
5
Our late breaking science presentation on device-related complications in the PRAETORIAN trial. Teamwork! @KnopsReinoud @SPepplinkhuizen #ESC #EHJ @ESC_Journals #ICD
1
2
9
RT @drsuneet: Congrats to @KnopsReinoud and the PRAETORIAN trial investigators on additional important analysis from this trial. #esccongre….
0
8
0
RT @fleurtjong: ⭐️Great late breaking science session! @KnopsReinoud presenting a secondary analysis of the PRAETORIAN trial: highlighting….
0
3
0
RT @fleurtjong: Very proud of my talented PhD students Maarten Kolk and Karel Breeman who are presenting later this conference on identifyi….
0
1
0
RT @sruiperez98: First day coming to an end at #esc2022 with wonderful people and extremely talented researchers and MDs: @fleurtjong @Mill….
0
3
0
0
1
2
0
0
8
RT @fleurtjong: #HRS2022 you’ve been great!! What a crew! The amazing Amsterdam @amsterdamumc HRS delegation & so many good friends! #EPeep….
0
6
0
RT @fleurtjong: Great session with key opinion leader, my friend & mentor and fantastic PI of our @CardiacDevices_ research group @KnopsRei….
0
3
0